Completed
Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)
NCT00038597
- Conditions
- Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
- Locations
-
- MDAnderson Cancer Center Houston, Texas, United States